• Mashup Score: 7

    On Nov 7, 2022, members of the White House Office of Science Technology Policy outlined plans for a US HCV elimination programme at a special session at AASLD’s The Liver Meeting. In a US context, the plan warrants praise for its ambition—many hurdles to successful elimination exist in the country, and progress has been slow and disjointed since the first interferon-free direct-acting antiviral…

    Tweet Tweets with this article
    • RT @LancetGastroHep: New Editorial - A US plan for HCV elimination https://t.co/aoTzGj8laV #hcv #hepC #nohep #endhep #livertwitter #idtwi…

  • Mashup Score: 0

    On Nov 7, 2022, members of the White House Office of Science Technology Policy outlined plans for a US HCV elimination programme at a special session at AASLD’s The Liver Meeting. In a US context, the plan warrants praise for its ambition—many hurdles to successful elimination exist in the country, and progress has been slow and disjointed since the first interferon-free direct-acting antiviral…

    Tweet Tweets with this article
    • New Editorial - A US plan for HCV elimination https://t.co/aoTzGj8laV #hcv #hepC #nohep #endhep #livertwitter #idtwitter https://t.co/xP2CCQBWVz

  • Mashup Score: 1

    Each year over a quarter of a million children acquire chronic hepatitis B at birth.1 Tens of thousands will go on to lose their lives prematurely from liver cancer or other forms of liver disease.1 These deaths could have been prevented if they had received the hepatitis B birth dose vaccine.

    Tweet Tweets with this article
    • An open letter to @gavi: hepatitis B birth dose vaccine can’t wait Signed by @CDAFound @GlobalHep @HepAus @EndHep2030 @HepBFoundation @MSF_access @PATHtweets #TREATAsia @amfAR @uicc @Hep_Alliance https://t.co/55Z06RJBMk #nohep #endhep #HBV @GaviSeth https://t.co/BcPs7d0AJw

  • Mashup Score: 1

    After more than 5 years of intense preclinical and clinical research, the development of new hepatitis B virus (HBV) drugs appears to be stalling. The main reasons for this are the major limitations of the developmental path, including the use of inappropriate endpoints for clinical development, the standards for efficacy and approval being too strict (functional cure after short finite treatment…

    Tweet Tweets with this article
    • New Personal View - @JMPawlotsky - New hepatitis B drug development disillusions: time to reset? https://t.co/J0xdokvOgK #hepB #HBV #nohep #endhep #livertwitter #TLM22

  • Mashup Score: 2

    Community engagement and advocacy are important to drive development and improvement of service delivery for chronic viral hepatitis. Community engagement is defined as the process of working collaboratively with groups of people affiliated by proximity, interests, or situations to support their wellbeing.1 Appropriate community engagement can help to reduce stigma, disseminate messages, and…

    Tweet Tweets with this article
    • Today is #WorldHepatitisDay. In a Comment, Eneyi Kpokiri and colleagues discuss expanding community engagement and advocacy in chronic viral hepatitis https://t.co/4S1qjIVUOE #nohep #endhep #idtwitter #livertwitter @Hep_Alliance https://t.co/gLuX5N90Qn